TCW Multisector Credit Income ETF MUSE 深 沪
等待开盘 12-20 09:30:00 美东时间
50.055
+0.050
+0.10%
华盛通- 最 高50.055
- 今 开50.005
- 成交量 13股
- 最 低 50.055
- 昨 收 50.005
- 总市值 5005.50万
- 52周最高 50.055
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 45.21
- 委 比 29.41%
- 总股本 100.00万
- 历史最高 50.055
- 量 比 0
- 振 幅 0.00%
- 历史最低 45.21
- 每 手 1
- 风险率 1.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why SciSparc Stock Is Gaining Today
SciSparc shares are surging after it moved to acquire MUSE endoscopy IP, broadening beyond neuroscience into GERD device commercialization.
11-26 23:15
SciSparc Strikes Deal To Acquire Patents For Single-Use Reflux Treatment Device MUSE
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., today announced the signing of a binding
11-26 20:43
网络攻击后，欧洲多座机场全力修复值机系统故障
伦敦希思罗机场 黑客攻击导致自动值机系统瘫痪后，欧洲多座大型机场于周日全力恢复正常运营。其中，布鲁塞尔机场因故障持续，要求航空公司取消周一半数出港航班。...
09-22 01:06
「穿户外」的人，正在「杀死」户外
作者：王利 编辑：王小坤 同一片土地，同一个市场，两家企业交出了相反的年中成绩单。 一边是探路者的“形势严峻、内部阵痛”，归母净利润同比暴跌74...
09-12 08:00
Vibrant Broadband Transforms Middle Mile Infrastructure with Ribbon
Achieves tenfold bandwidth increase, streamlined deployment, and increased network visibility PLANO, Texas, Aug. 18, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global ...
08-18 20:00
全球首款！光伏领域最新成果惊艳亮相2025上海别墅展！
在全球能源转型和可持续发展的大背景下，建筑作为碳排放的重要载体，其绿色转型已不仅是技术命题，更关乎人类对 “栖居” 本质的重新审视。在 “双碳” 目标与建筑美学...
08-11 17:32
Alterity Faces ASX Scrutiny Over Timing of Market-Sensitive MRI Study Announcement
Alterity Therapeutics Limited (‘ATH'): ASX Aware LetterASX refers to the following:A.ATH's announcement titled ‘Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study'
08-04 19:59
Alterity Therapeutics Says Peer-Reviewed Publication In Annals Of Clinical And Translational Neurology Highlights Use Of MSA Atrophy Index Developed To Diagnose And Track Disease Progression In Multiple System Atrophy
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an
07-24 19:28
Alterity Therapeutics Presents MSA Research At 2025 International MSA Congress; ATH434 Phase 2 Data Shows Clinically Meaningful Efficacy On Multiple Clinical Endpoints
– ATH434 Phase 2 data demonstrated clinically meaningful efficacy on multiple clinical endpoints –– MSA Atrophy Index (MSAai) enhances MSA diagnosis and monitoring –– bioMUSE Study shows higher α- synuclein concentration
05-12 19:39
361度2025年首季开门红：科技赋能增长，多维布局驱动品牌全球化跃升
4月14日，国内领先体育运动品牌361度(01361.HK)公布了2025年第一季度运营成果，数据显示，公司主品牌零售额同比增长10%–15%，童装业务零售额同...
04-15 09:07
